Eric M. Meslin
Founding Director, Indiana University Center for Bioethics
Associate Dean for Bioethics
Professor of Medicine, Medical and Molecular Genetics, Public Health and Philosophy
Indiana University
Indianapolis, Indiana
USA

Dr. Eric Meslin is Founding Director of the Indiana University Center for Bioethics, Associate Dean for Bioethics and Professor of Medicine, Medical and Molecular Genetics, Public Health and Philosophy.

He came to Indiana University in July 2001 from the National Bioethics Advisory Commission (NBAC), where he had been Executive Director since 1998. NBAC was appointed by President Bill Clinton to advise the White House and the federal government on a range of bioethics issues including cloning, stem cell research, international clinical trials, and genetics studies. Prior to his work at NBAC, Meslin was Program Director in the Ethical, Legal and Social Implications (ELSI) program at the National Human Genome Research Institute.

A Canadian by birth, Dr. Meslin received his B.A. in Philosophy from York University in Toronto, and both his M.A. and Ph.D. from the Bioethics Program in Philosophy at the Kennedy Institute of Ethics at Georgetown University. He has held academic positions at the University of Toronto (1988-96) and at Oxford University (1994-95) and in addition to his Indiana University appointments, is also Visiting Professor-at-Large at the University of Western Australia.

He has more than 100 publications on topics ranging from international health research to science policy, including Belmont Revisited: Ethical Principles for Research with Human Subjects (2005) co-edited with James F. Childress and Harold T. Shapiro.

He has been a consultant to the World Health Organization, the US Observer Mission to UNESCO, the Canadian Institutes of Health Research and sits on several boards and committees including the Stem Cell Oversight Committee of the Juvenile Diabetes Research Foundation, the Indiana Public Umbilical Cord Blood Bank (Appointed by Governor Mitch Daniels), and the Board of Directors of Genome Canada. On May 9, 2007 he was appointed a Chevalier de L’Ordre National du Mérite (Knight of the National Order of Merit) by the President of France.

Back